Ravindra Kumar
Chief Tech/Sci/R&D Officer bei ACCELERON PHARMA INC.
Profil
Ravindra Kumar ist Chief Scientific Officer & Senior Vice President bei Acceleron Pharma, Inc. In der Vergangenheit hatte Dr. Kumar die Position des Principal Scientist bei Genetics Institute LLC und des Senior Scientist bei Wyeth Pharmaceuticals LLC inne. Dr. Kumar erhielt einen Doktortitel von der University of New Brunswick, einen Hochschulabschluss von der Chaudhary Charan Singh University und einen Bachelor-Abschluss von der Mahatma Jyotiba Phule Rohilkhand University.
Aktive Positionen von Ravindra Kumar
| Unternehmen | Position | Beginn |
|---|---|---|
| ACCELERON PHARMA INC. | Chief Tech/Sci/R&D Officer | 01.10.2012 |
| BCL INDUSTRIES LIMITED | Chief Operating Officer | - |
Ehemalige bekannte Positionen von Ravindra Kumar
| Unternehmen | Position | Ende |
|---|---|---|
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | - |
| GLOBUS SPIRITS LIMITED | Corporate Officer/Principal | - |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von Ravindra Kumar
| University of New Brunswick | Doctorate Degree |
| Chaudhary Charan Singh University | Graduate Degree |
| Mahatma Jyotiba Phule Rohilkhand University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BCL INDUSTRIES LIMITED | Consumer Non-Durables |
| GLOBUS SPIRITS LIMITED | Consumer Non-Durables |
| Private Unternehmen | 3 |
|---|---|
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
